Home ›
Entities
› academia
› Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein
Research article (Neuro-Oncology, 2020) · cited 103× · AI/ML
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein
Summary
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein is a scholarly article[1].
Key Facts
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein. Retrieved May 24, 2026, from https://4ort.xyz/entity/entrectinib-a-trk-ros1-inhibitor-with-anti-cns-tumor-activity-differentiation-from-other-inhibitors-in-its-class-due-to-
MLA“Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/entrectinib-a-trk-ros1-inhibitor-with-anti-cns-tumor-activity-differentiation-from-other-inhibitors-in-its-class-due-to-.
BibTeX@misc{4ortxyz_entrectinib-a-trk-ros1-inhibitor-with-anti-cns-tumor-activity-differentiation-from-other-inhibitors-in-its-class-due-to-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein}}, year = {2026}, url = {https://4ort.xyz/entity/entrectinib-a-trk-ros1-inhibitor-with-anti-cns-tumor-activity-differentiation-from-other-inhibitors-in-its-class-due-to-}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein — https://4ort.xyz/entity/entrectinib-a-trk-ros1-inhibitor-with-anti-cns-tumor-activity-differentiation-from-other-inhibitors-in-its-class-due-to- (retrieved 2026-05-24)
